AlphaYouCTSO: Sobel Alan D. discloses a purchase
By AlphaYouPublished Form 4
Sobel Alan D.
Reporting filer
Sobel Alan D. reported Purchase in Cytosorbents Corp: 1900 units of Common Stock, dated 2026-09-15. The full Form 4 contains 3 transaction entries.
- Disclosed
- Sep 16, 2026
Reported details
3 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Sobel Alan D. | 2026-09-15 | P | Purchase | 1900 | 6.12 | 9,287 | 1 day | Filed terms
|
| Common Stock | Sobel Alan D. | 2026-09-15 | P | Purchase | 500 | 6.05 | 9,787 | 1 day | Filed terms
|
| Common Stock | Sobel Alan D. | 2026-09-15 | P | Purchase | 100 | 6.01 | 9,887 | 1 day | Filed terms
|
Common Stock
- Owner
- Sobel Alan D.
- Date
- 2026-09-15
- Code
- P
- Action
- Purchase
- Quantity
- 1900
- Price
- 6.12
- Following holdings
- 9,287
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-15
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: P
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 1900
- transaction Price Per Share: 6.12
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 9287
- id: F1
- id: F2
- id: F3
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Sobel Alan D.
- Date
- 2026-09-15
- Code
- P
- Action
- Purchase
- Quantity
- 500
- Price
- 6.05
- Following holdings
- 9,787
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-15
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: P
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 500
- transaction Price Per Share: 6.05
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 9787
- id: F1
- id: F2
- id: F3
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Sobel Alan D.
- Date
- 2026-09-15
- Code
- P
- Action
- Purchase
- Quantity
- 100
- Price
- 6.01
- Following holdings
- 9,887
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-15
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: P
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 100
- transaction Price Per Share: 6.01
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 9887
- id: F1
- id: F2
- id: F3
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Sobel Alan D.: Director.
- F1: These transactions reported on this Form 4 reflect open market purchases made by the Reporting Person.
- F2: Includes (i) the following restricted stock units ("RSUs") that will be settled into Common Stock upon vesting upon a "Change in Control" of CytoSorbents Corporation (the "Issuer"), as defined in the CytoSorbents Corporation 2014 Long-Term Incentive Plan (the "Plan"): (a) 165 RSUs granted on March 15, 2018, (b) 300 RSUs granted on February 24, 2017, (c) 250 RSUs granted on June 7, 2016, and (d) 2,750 RSUs granted on April 8, 2015 and (ii) 6,422 shares of Common Stock owned directly by the Reporting Person.
- F3: Reflects the 1-for-20 reverse stock split effected by the Issuer on September 8, 2026.
Original sources
Prepared automatically from public filing data. Report a correction.